Kangmei Pharmaceutical: Net profit attributable to mothers in the first quarter was a loss of 40.42 million yuan.

CanSino announced on April 28 that the company achieved operating revenue of 190 million yuan in the first quarter of 2026, an increase of 38.73% year-on-year; the net profit attributable to shareholders of the listed company was a loss of 40.42 million yuan, compared to a loss of 11.54 million yuan for the same period last year; basic earnings per share was -0.16 yuan.